Dr. Hepper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7813 Shrader Rd
Henrico, VA 23294Phone+1 804-264-4545
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Dermatopathology, 2011 - 2012- Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 2008 - 2011
Vanderbilt University School of MedicineClass of 2007
Certifications & Licensure
FL State Medical License 2022 - Present
VA State Medical License 2013 - 2026
MD State Medical License 2012 - 2014
MO State Medical License 2007 - 2012- American Board of Dermatology Dermatology
- American Board of Dermatology Dermatopathology
Publications & Presentations
PubMed
- 14 citationsHistopathologic characteristics of therapy-associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma.Kari E. Sufficool, Donna M. Hepper, Gerald P. Linette, Eva A. Hurst, Dongsi Lu
Journal of Cutaneous Pathology. 2014-07-01 - 23 citationsHistopathology of acneiform eruptions in patients treated with epidermal growth factor receptor inhibitors.Lindsey A. Brodell, Donna M. Hepper, Anne C. Lind, Alejandro A. Gru, Milan J. Anadkat
Journal of Cutaneous Pathology. 2013-10-01 - 74 citationsCutaneous Toxic Effects Associated With Vemurafenib and Inhibition of the BRAF PathwayVictor Huang, Donna M. Hepper, Milan J. Anadkat, Lynn A. Cornelius
Archives of Dermatology. 2012-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
